ArticlePathogens & immunity2017

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial.

Pablo F Belaunzarán-Zamudio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.